Inhibiting EBV: The Key to Carefree Smooching

Immunity. 2018 Apr 17;48(4):623-625. doi: 10.1016/j.immuni.2018.03.036.


There are no vaccines or therapies to treat Epstein-Barr virus (EBV). Snijder et al. (2018) isolated a potent human antibody against EBV that blocks infection of both B cells and epithelial cells. Structural analysis of the antibody complexed with a viral surface protein complex identified a site that may be useful in vaccine development.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies*
  • B-Lymphocytes
  • Epithelial Cells
  • Herpesvirus 4, Human*
  • Humans


  • Antibodies